Itau USA Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-16,232
Closed -$455K 105
2014
Q3
$455K Hold
16,232
0.1% 45
2014
Q2
$457K Hold
16,232
0.12% 54
2014
Q1
$495K Sell
16,232
-4,005
-20% -$119K 0.16% 43
2013
Q4
$588K Hold
20,237
0.15% 67
2013
Q3
$552K Sell
20,237
-4,110
-17% -$112K 0.14% 69
2013
Q2
$647K Buy
+24,347
New +$673K 0.16% 63

Other funds holding PFE

Itau USA Asset Management's PFE Position: Q4 2014 in Review

Itau USA Asset Management sold out of Pfizer (PFE) in Q4 2014, closing a stake of 16,232 shares — an estimated $455K sold.

Itau USA Asset Management first reported a position in PFE in Q2 2013 and held it in 6 quarters. The position peaked at $647K in Q2 2013. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Itau USA Asset Management reported no remaining Pfizer position as of Q4 2014 after selling out during the quarter.
  • Itau USA Asset Management sold 16,232 Pfizer shares in Q4 2014, an estimated $455K.
  • Itau USA Asset Management first reported a position in Pfizer in Q2 2013 and held it in 6 quarters.
  • Itau USA Asset Management's Pfizer position peaked at $647K in Q2 2013.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Itau USA Asset Management's 13F filing for Q4 2014, filed 6 Feb 2015.